Algesia CR Cap
Macleods Pharmaceuticals Pvt Ltd - capsule - 10 S
Standard delivery
₹137
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated June 2026
Medicines with the same active ingredient and strength as Sitadapa 50/5MG Tab 10S.
You are viewing
Sitadapa 50/5MG Tab 10S
tablet - 10 S
₹133
₹13.31 per tablet
D EARTH PHARMACEUTICALS · tablet - 10 S · Rx
₹89
₹8.90 per tablet
Zuventus Healthcare Ltd · tablet - 10 S · Rx
₹102
₹10.20 per tablet
Sitagliptin 50 mg + Dapagliflozin 5 mg (as tablets)
Type 2 diabetes mellitus: to improve glycaemic control in adults as an adjunct to diet and exercise when dual therapy is appropriate.
Sitagliptin is a DPP-4 inhibitor that increases incretin levels, enhancing glucose-dependent insulin release and reducing glucagon. Dapagliflozin is an SGLT2 inhibitor that reduces renal glucose reabsorption, increasing urinary glucose excretion and lowering blood glucose.
Oral tablet. Take exactly as prescribed, usually once daily, with or without food. Maintain adequate hydration; follow diet/exercise plan and monitor blood glucose as advised.
Common side effects of Sitadapa 50/5MG Tab 10S may include:
Macleods Pharmaceuticals Pvt Ltd - capsule - 10 S
Standard delivery
Macleods Pharmaceuticals Pvt Ltd - 100 ml
Standard delivery
Macleods Pharmaceuticals Pvt Ltd - 10 S
Standard delivery
Macleods Pharmaceuticals Pvt Ltd - tablet - 10 S
Standard delivery
Macleods Pharmaceuticals Pvt Ltd - 10 mg - 15 S
Standard delivery
Macleods Pharmaceuticals Pvt Ltd - tablet - 15 Tablet
Standard delivery
Macleods Pharmaceuticals Pvt Ltd - tablet - 15 Tablet
Standard delivery
Macleods Pharmaceuticals Pvt Ltd - 15 s
Standard delivery
A substitute contains the same active ingredient (salt), in the same strength, as Sitadapa 50/5MG Tab 10S. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Not for type 1 diabetes or diabetic ketoacidosis. Risk of dehydration/low blood pressure, genital mycotic infections, UTIs and rare urosepsis/pyelonephritis with dapagliflozin; maintain hydration and seek care for fever, flank pain or burning urination. SGLT2 inhibitors may rarely cause euglycaemic ketoacidosis—seek urgent care for nausea/vomiting, abdominal pain, rapid breathing, or unusual fatigue. Sitagliptin may rarely cause pancreatitis and serious allergic reactions; stop and seek care for severe abdominal pain or rash/swelling. Use with caution in renal impairment; dose/continuation depends on eGFR—doctor monitoring required. Monitor for hypoglycaemia when used with insulin or sulfonylureas.